These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Dual-Functional MN-08 Attenuated Pulmonary Arterial Hypertension Through Vasodilation and Inhibition of Pulmonary Arterial Remodeling. Luo F; Wu L; Xie G; Gao F; Zhang Z; Chen G; Liu Z; Zha L; Zhang G; Sun Y; Zhang Z; Wang Y Hypertension; 2021 May; 77(5):1787-1798. PubMed ID: 33775126 [TBL] [Abstract][Full Text] [Related]
9. [A systematic review as a method of gathering scientific evidence into clinical guidelines: CHEST-2019 guideline for the therapy pulmonary arterial hypertension in adults]. Shmalts AA; Gorbachevsky SV Ter Arkh; 2019 Dec; 91(12):105-114. PubMed ID: 32598597 [TBL] [Abstract][Full Text] [Related]
10. POINT: Should Initial Combination Therapy Be the Standard of Care in Pulmonary Arterial Hypertension? Yes. Humbert M; Lau EMT Chest; 2019 Dec; 156(6):1039-1042. PubMed ID: 31812188 [No Abstract] [Full Text] [Related]
11. Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management. Correale M; Tricarico L; Grazioli D; Formica ES; Petrucci R; Persichella P; Di Biase M; Brunetti ND Cardiovasc Drugs Ther; 2019 Dec; 33(6):725-738. PubMed ID: 31811420 [TBL] [Abstract][Full Text] [Related]
12. Epoprostenol therapy for pulmonary arterial hypertension: the first Polish experience. Kopeć G; Waligóra M; Jonas K; Stępniewski J; Magoń W; Podolec P Pol Arch Intern Med; 2019 Jan; 129(1):65-68. PubMed ID: 30543197 [No Abstract] [Full Text] [Related]
13. Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension. Sánchez-Gloria JL; Osorio-Alonso H; Arellano-Buendía AS; Carbó R; Hernández-Díazcouder A; Guzmán-Martín CA; Rubio-Gayosso I; Sánchez-Muñoz F Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650586 [TBL] [Abstract][Full Text] [Related]
14. Targeting sphingosine kinase 1 for the treatment of pulmonary arterial hypertension. Yang K; Jiang K; Xu Z; Song Y; Wang J Future Med Chem; 2019 Nov; 11(22):2939-2953. PubMed ID: 31713437 [TBL] [Abstract][Full Text] [Related]
16. [Pulmonary arterial hypertension from the risk assessment to combined treatment]. Santos-Martínez LE; Moreno-Ruiz LA; Cabrera-Ramírez C; Mendoza-Pérez BC; Galván-Oseguera H; Magaña-Serrano JA; Lupercio-Mora K; Saturno-Chiu G Rev Med Inst Mex Seguro Soc; 2019 Sep; 57(5):314-323. PubMed ID: 32568487 [TBL] [Abstract][Full Text] [Related]
17. Use of the Prostacyclin Receptor Agonist Selexipag in Patients With Pulmonary Arterial Hypertension Associated With Eisenmenger Syndrome. Demerouti EA; Karyofyllis P; Apostolopoulou SC Can J Cardiol; 2021 Aug; 37(8):1286-1288. PubMed ID: 33539988 [TBL] [Abstract][Full Text] [Related]
18. Modeling of Acute Pulmonary Arterial Hypertension in Pigs Using a Stable Thromboxane A Goncharova NS; Andreeva EM; Vakhrushev AD; Leandro HIC; Murashova LA; Voronin SE; Korobchenko LE; Mitrofanova LB; Skorik YA; Galagudza MM; Moiseeva OM; Mikhaylov EN Bull Exp Biol Med; 2021 Apr; 170(6):729-733. PubMed ID: 33893968 [TBL] [Abstract][Full Text] [Related]
19. Fulvestrant for the Treatment of Pulmonary Arterial Hypertension. Kawut SM; Pinder D; Al-Naamani N; McCormick A; Palevsky HI; Fritz J; Smith KA; Mazurek JA; Doyle MF; MacLean MR; DeMichele A; Mankoff DA Ann Am Thorac Soc; 2019 Nov; 16(11):1456-1459. PubMed ID: 31314997 [No Abstract] [Full Text] [Related]
20. Pulmonary arterial hypertension specific therapy: The old and the new. Zolty R Pharmacol Ther; 2020 Oct; 214():107576. PubMed ID: 32417272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]